TY - JOUR
T1 - Activation of activin type IB receptor signals in pancreatic β cells leads to defective insulin secretion through the attenuation of ATP-sensitive K+ channel activity
AU - Nomura, Masatoshi
AU - Morinaga, Hidetaka
AU - Zhu, Hai Lei
AU - Wang, Lixiang
AU - Hasuzawa, Nao
AU - Takayanagi, Ryoichi
AU - Teramoto, Noriyoshi
N1 - Funding Information:
This work was supported by both a Grant-in-Aid for Scientific Research (C) from the Japanese Society for the Promotion of Science (JSPS) (Masatoshi Nomura, Grant Number 26461383 ) and a Grant-in-Aid for Scientific Research (B) from the JSPS (Noriyoshi Teramoto, Grant Number 26282148 ).
PY - 2014/7/18
Y1 - 2014/7/18
N2 - In studies of gene-ablated mice, activin signaling through activin type IIB receptors (ActRIIB) and Smad2 has been shown to regulate not only pancreatic β cell mass but also insulin secretion. However, it still remains unclear whether gain of function of activin signaling is involved in the modulation of pancreatic β cell mass and insulin secretion. To identify distinct roles of activin signaling in pancreatic β cells, the Cre-loxP system was used to activate signaling through activin type IB receptor (ActRIB) in pancreatic β cells. The resultant mice (pancreatic β cell-specific ActRIB transgenic (Tg) mice; ActRIBCAβTg) exhibited a defect in glucose-stimulated insulin secretion (GSIS) and a progressive impairment of glucose tolerance. Patch-clamp techniques revealed that the activity of ATP-sensitive K+ channels (KATP channels) was decreased in mutant β cells. These results indicate that an appropriate level of activin signaling may be required for GSIS in pancreatic β cells, and that activin signaling involves modulation of KATP channel activity.
AB - In studies of gene-ablated mice, activin signaling through activin type IIB receptors (ActRIIB) and Smad2 has been shown to regulate not only pancreatic β cell mass but also insulin secretion. However, it still remains unclear whether gain of function of activin signaling is involved in the modulation of pancreatic β cell mass and insulin secretion. To identify distinct roles of activin signaling in pancreatic β cells, the Cre-loxP system was used to activate signaling through activin type IB receptor (ActRIB) in pancreatic β cells. The resultant mice (pancreatic β cell-specific ActRIB transgenic (Tg) mice; ActRIBCAβTg) exhibited a defect in glucose-stimulated insulin secretion (GSIS) and a progressive impairment of glucose tolerance. Patch-clamp techniques revealed that the activity of ATP-sensitive K+ channels (KATP channels) was decreased in mutant β cells. These results indicate that an appropriate level of activin signaling may be required for GSIS in pancreatic β cells, and that activin signaling involves modulation of KATP channel activity.
UR - http://www.scopus.com/inward/record.url?scp=84904758835&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84904758835&partnerID=8YFLogxK
U2 - 10.1016/j.bbrc.2014.05.141
DO - 10.1016/j.bbrc.2014.05.141
M3 - Article
C2 - 24928396
AN - SCOPUS:84904758835
SN - 0006-291X
VL - 450
SP - 440
EP - 446
JO - Biochemical and Biophysical Research Communications
JF - Biochemical and Biophysical Research Communications
IS - 1
ER -